1. Cancer statistics, 2017;Siegel;CA Cancer J Clin,2017
2. Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion;Harris;Nat Clin Pract Urol,2009
3. Sanofi. TAXOTERE® (docetaxel) US Prescribing Information. Revised 2015.
4. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Prostate Cancer (Version 2.2017). 2017.
5. Antiproliferative mechanism of action of the novel taxane cabazitaxel as compared with the parent compound docetaxel in MCF7 breast cancer cells;Azarenko;Mol Cancer Ther,2014